(firstQuint)An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects.

 Study includes two treatment periods: period 1 is single dose of PF-06372865 given alone followed by at least 5-day washout out.

 The period 2 is 200 mg QD itraconazole given for 8 days with PF-06372865 single dose co-administered on day 4 (1 hour later than itraconazole dose).

 The PK and safety will be assessed and compared for single dose of PF-06372865 in period 1 and period 2.

.

 An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects@highlight

The purpose of this study is to evaluate the effect of itraconazole after multiple dose administration on the single dose PK of PF-06372865.

